Search

everythinglearnresearchcommunity

for

Search:↓

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Higher testosterone and lower Vitamin D levels are linked to hair loss in female COVID-19 patients.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Topical Minoxidil is effective for hair loss after COVID-19.

COVID-19 can cause various skin issues, like rashes and hair loss, which help in early diagnosis.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Women with high androgen levels may have more severe COVID-19 symptoms.

Men had worse COVID-19 outcomes than women in New York City.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

New-onset fibromyalgia after COVID-19 is poorly understood, needing better definitions and studies.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

The random forest model effectively helps diagnose COVID-19 using key factors like age and symptoms.

Collider bias can distort our understanding of COVID-19 risk and severity.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

COVID-19 can harm male fertility by reducing sperm stem cells and damaging testicular function.

Non-Kuwaitis with COVID-19 had higher chances of severe outcomes than Kuwaitis.

COVID-19 infection may cause hair loss.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.